Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01349413Phase 4Completed
Phase 4, randomised, double-blind trial in functional dyspepsia (FD) comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Proportion of patients who report positive response to adequate relief of dyspeptic symptoms at 8 weeks. Started Aug 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01349413.